Page 2 - Global Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Mar 08, 2026

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,016 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ONESOURCE	₹1,480.50	13.1%	1.5%	₹169.7b	₹1,946.75	816.2	115.8%	n/a
INDOCO	₹198.36	-1.2%	-14.0%	₹18.3b	₹268.00	1.0	115.6%	0.1%
GUARD	SEK 1.60	-3.0%	-90.4%	SEK 32.3m	SEK 1.75	0.8	115.0%	n/a
A009420	₩52,000.00	-15.7%	46.5%	₩2.8t	₩54,800.00	1142.9	113.7%	n/a
688520	CN¥39.36	3.1%	-3.0%	CN¥17.8b	CN¥49.00	11.2	113.4%	n/a
2228	HK$9.74	0%	45.8%	HK$43.3b	HK$9.99	54.5	113.3%	n/a
1477	HK$6.74	-2.6%	41.9%	HK$5.7b	HK$9.92	8.9	113.1%	n/a
A394800	₩13,070.00	-9.6%	138.5%	₩451.3b	n/a	42.4	113.0%	n/a
IDLDX	SEK 0.35	0%	-30.9%	SEK 80.4m	SEK 1.00	1.5	112.9%	n/a
TRUL	CA$9.10	10.8%	54.0%	CA$1.7b	CA$19.72	1.1	112.2%	n/a
300676	CN¥44.53	-5.2%	-29.2%	CN¥17.3b	CN¥57.72	4.6	112.2%	0%
A003220	₩10,200.00	-10.8%	-27.8%	₩229.3b	₩15,333.33	0.9	112.2%	2.9%
FYB	€19.74	-11.7%	-21.5%	€348.7m	€40.71	7.3	111.6%	n/a
HBIO	US$0.55	-6.9%	-28.9%	US$24.6m	US$2.00	1.7	111.3%	n/a
MAGLE	SEK 7.80	0%	-75.0%	SEK 161.1m	SEK 35.00	0.3	111.2%	n/a
HITI	CA$3.35	-2.3%	1.2%	CA$294.3m	CA$7.50	3.4	111.0%	n/a
603108	CN¥14.90	-2.6%	-34.8%	CN¥9.0b	CN¥20.00	1.2	110.6%	0.2%
BINV	SEK 22.70	1.6%	-13.2%	SEK 1.5b	SEK 90.00	6.6	110.2%	n/a
300122	CN¥16.17	-2.8%	-35.5%	CN¥38.7b	CN¥24.78	3.5	109.0%	1.2%
VITR	SEK 93.65	0.8%	-43.2%	SEK 12.7b	SEK 176.75	3.7	108.4%	1.2%
2171	HK$13.92	13.5%	-5.4%	HK$6.0b	HK$21.37	54.5	108.3%	n/a
TLRY	US$7.21	-5.1%	10.8%	US$840.0m	US$11.73	1.0	105.1%	n/a
FBIO	US$3.34	1.2%	92.0%	US$103.7m	US$10.75	1.7	105.0%	n/a
ARX	AU$0.62	-6.1%	26.5%	AU$214.2m	n/a	2.8	104.1%	n/a

Page 2 of 126